Cargando…
Correction: Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
Autores principales: | Xu, Yang, Liu, Zhen, Sun, Jie, Pan, Qiangrong, Sun, Feifei, Yan, Zhiyu, Hu, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286122/ http://dx.doi.org/10.1371/annotation/7a1b01e4-b894-40ef-9c31-584e9c24ee0a |
Ejemplares similares
-
Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
por: Xu, Yang, et al.
Publicado: (2011) -
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022) -
Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2019) -
Correction to: Gasdermin D mediates endoplasmic reticulum stress via FAM134B to regulate cardiomyocyte autophagy and apoptosis in doxorubicin-induced cardiotoxicity
por: Qu, Ya’nan, et al.
Publicado: (2022) -
Correction for: miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
por: Yin, Zhongwei, et al.
Publicado: (2021)